Chang Cl

1.4k total citations
29 papers, 1.0k citations indexed

About

Chang Cl is a scholar working on Surgery, Cardiology and Cardiovascular Medicine and Oncology. According to data from OpenAlex, Chang Cl has authored 29 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Surgery, 6 papers in Cardiology and Cardiovascular Medicine and 5 papers in Oncology. Recurrent topics in Chang Cl's work include Reproductive Health and Contraception (5 papers), Cancer Immunotherapy and Biomarkers (4 papers) and Anesthesia and Sedative Agents (4 papers). Chang Cl is often cited by papers focused on Reproductive Health and Contraception (5 papers), Cancer Immunotherapy and Biomarkers (4 papers) and Anesthesia and Sedative Agents (4 papers). Chang Cl collaborates with scholars based in Taiwan, United States and Japan. Chang Cl's co-authors include Michael Marmot, Poulter Nr, Farley Tm, Olav Meirik, T.‐C. Wu, Chien‐Fu Hung, Neil R Poulter, Chin‐Yo Lin, Peter Sever and Yih‐Sharng Chen and has published in prestigious journals such as Annals of Oncology, Gene Therapy and European Journal of Clinical Microbiology & Infectious Diseases.

In The Last Decade

Chang Cl

27 papers receiving 991 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Chang Cl Taiwan 10 519 339 288 266 185 29 1.0k
Farley Tm 5 518 1.0× 337 1.0× 288 1.0× 248 0.9× 183 1.0× 10 922
Nathalie Trillot France 12 116 0.2× 205 0.6× 265 0.9× 188 0.7× 28 0.2× 35 1.1k
Marie‐Hélène Horellou France 15 100 0.2× 358 1.1× 338 1.2× 281 1.1× 38 0.2× 31 787
Donald L. Yee United States 20 51 0.1× 555 1.6× 329 1.1× 383 1.4× 54 0.3× 56 1000
D. Marchesoni Italy 21 256 0.5× 95 0.3× 22 0.1× 55 0.2× 331 1.8× 108 1.2k
A.‐C. Teger‐Nilsson Sweden 14 76 0.1× 317 0.9× 153 0.5× 197 0.7× 15 0.1× 37 940
Robert J. Porte Netherlands 22 127 0.2× 402 1.2× 81 0.3× 71 0.3× 18 0.1× 50 1.8k
John Will United States 14 43 0.1× 262 0.8× 99 0.3× 117 0.4× 70 0.4× 29 753
Steven T. Bird United States 16 233 0.4× 28 0.1× 15 0.1× 52 0.2× 122 0.7× 31 736
Robert F. Sidonio United States 22 45 0.1× 1.7k 4.9× 84 0.3× 181 0.7× 106 0.6× 129 2.1k

Countries citing papers authored by Chang Cl

Since Specialization
Citations

This map shows the geographic impact of Chang Cl's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chang Cl with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chang Cl more than expected).

Fields of papers citing papers by Chang Cl

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chang Cl. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chang Cl. The network helps show where Chang Cl may publish in the future.

Co-authorship network of co-authors of Chang Cl

This figure shows the co-authorship network connecting the top 25 collaborators of Chang Cl. A scholar is included among the top collaborators of Chang Cl based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chang Cl. Chang Cl is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
Tewari, Krishnansu S., Bradley J. Monk, Ignace Vergote, et al.. (2021). VP4-2021: EMPOWER-Cervical 1/GOG-3016/ENGOT-cx9: Interim analysis of phase III trial of cemiplimab vs. investigator's choice (IC) chemotherapy (chemo) in recurrent/metastatic (R/M) cervical carcinoma. Annals of Oncology. 32(7). 940–941. 20 indexed citations
4.
5.
Prieto‐Merino, David, Joanna Dobson, Ajay Gupta, et al.. (2013). ASCORE: an up-to-date cardiovascular risk score for hypertensive patients reflecting contemporary clinical practice developed using the (ASCOT-BPLA) trial data. Journal of Human Hypertension. 27(8). 492–496. 9 indexed citations
6.
Cl, Chang, et al.. (2013). Effects of Ixeris Chinensis (Thunb.) Nakai boiling water extract on hepatitis B viral activity and hepatocellular carcinoma. African Journal of Traditional Complementary and Alternative Medicines. 11(1). 187–93. 10 indexed citations
7.
Gupta, Anubhav, Chang Cl, David Collier, et al.. (2011). 758 THE RELATIONSHIP BETWEEN STATIN THERAPY AND PROGRESSION OF RENAL DAMAGE AMONG 10305 HYPERTENSIVE PATIENTS RANDOMISED IN THE ASCOT-LIPID-LOWERING ARM (LLA). Atherosclerosis Supplements. 12(1). 158–159. 6 indexed citations
8.
Cl, Chang, T.‐C. Wu, & Chien‐Fu Hung. (2007). Control of human mesothelin-expressing tumors by DNA vaccines. Gene Therapy. 14(16). 1189–1198. 37 indexed citations
9.
Chen, Yih‐Sharng, et al.. (2002). Residential Water Supply as a Likely Cause of Community-Acquired Legionnaires' Disease in an Immunocompromised Host. European Journal of Clinical Microbiology & Infectious Diseases. 21(10). 706–709. 11 indexed citations
10.
Cl, Chang, et al.. (1999). Fabrication of 3-D Microcoils with Ferromagnetic Cores Using a Standard CMOS Process. 1 indexed citations
11.
Nr, Poulter, Chang Cl, Farley Tm, Olav Meirik, & Michael Marmot. (1996). Haemorrhagic stroke, overall stroke risk, and combined oral contraceptives: results of an international, multicentre, case-control study. WHO Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception.. PubMed. 348(9026). 505–10. 82 indexed citations
12.
Cl, Chang, et al.. (1996). Changes of propofol levels in isolated cardiopulmonary bypass circuit.. PubMed. 34(1). 17–20. 3 indexed citations
13.
Nr, Poulter, Chang Cl, Farley Tm, Olav Meirik, & Michael Marmot. (1995). Venous thromboembolic disease and combined oral contraceptives: results of international multicentre case-control study. World Health Organization Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception.. PubMed. 346(8990). 1575–82. 324 indexed citations
14.
Tm, Farley, Olav Meirik, Chang Cl, Michael Marmot, & Poulter Nr. (1995). Effect of different progestagens in low oestrogen oral contraceptives on venous thromboembolic disease. World Health Organization Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception.. PubMed. 346(8990). 1582–8. 274 indexed citations
15.
Cl, Chang, et al.. (1994). [Resections of tracheal or bronchial tumors and tracheal or bronchoplasty: experience with 53 patients].. PubMed. 32(9). 556–8.
16.
Tsai, Y-C, et al.. (1993). Prolonged fasting in pediatric outpatients does not cause hypoglycemia.. PubMed. 31(4). 249–52. 1 indexed citations
17.
Cl, Chang, et al.. (1990). [Renal effect of isoflurane].. PubMed. 28(4). 410–8. 7 indexed citations
18.
Cl, Chang, et al.. (1985). Effects of sodium nitroprusside-induced hypotension on the cerebral and hindlimb blood flow in dogs.. PubMed. 9(3). 202–7. 3 indexed citations
19.
Cl, Chang, et al.. (1984). Hepatic insulin resistance in non-insulin-dependent diabetes mellitus and the effects of a sulfonylurea in potentiating insulin action.. PubMed. 7 Suppl 1. 47–53. 9 indexed citations
20.
Cl, Chang. (1984). The effect of pituitary homografts on the accessory sex organs and serum hormonal levels with or without androgen in mature male rats.. PubMed. 8(2). 129–34. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Farley Tm Breakdown of academic impact, for papers by Nathalie Trillot Breakdown of academic impact, for papers by Marie‐Hélène Horellou Breakdown of academic impact, for papers by Donald L. Yee Breakdown of academic impact, for papers by D. Marchesoni Breakdown of academic impact, for papers by A.‐C. Teger‐Nilsson Breakdown of academic impact, for papers by Robert J. Porte Breakdown of academic impact, for papers by John Will Breakdown of academic impact, for papers by Steven T. Bird Breakdown of academic impact, for papers by Robert F. Sidonio
Rankless by CCL
2026